Trump’s tariffs pushed 2 firms to pour billions into the US
Tariffs are usually framed as a blunt weapon that raises prices and rattles allies, but in the pharmaceutical and manufacturing sectors they have also become a lever for redirecting investment. When President Donald Trump tied trade penalties to where critical drugs and components are made, two global firms responded by steering multibillion dollar projects into…